🇺🇸 FDA
Patent

US 10047396

Biomarkers for diagnosis of transient ischemic attacks

granted A61KA61K31/37A61K31/4365

Quick answer

US patent 10047396 (Biomarkers for diagnosis of transient ischemic attacks) held by The Regents of the University of California expires Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 14 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/37, A61K31/4365, A61K31/4439, A61K31/616